HomeCompareEMLAF vs MRK

EMLAF vs MRK: Dividend Comparison 2026

EMLAF yields 1.71% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMLAF wins by $376.5K in total portfolio value· pulled ahead in Year 5
10 years
EMLAF
EMLAF
● Live price
1.71%
Share price
$36.30
Annual div
$0.62
5Y div CAGR
68.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$433.3K
Annual income
$265,411.90
Full EMLAF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EMLAF vs MRK

📍 EMLAF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMLAFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMLAF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMLAF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMLAF
Annual income on $10K today (after 15% tax)
$145.00/yr
After 10yr DRIP, annual income (after tax)
$225,600.12/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, EMLAF beats the other by $217,271.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMLAF + MRK for your $10,000?

EMLAF: 50%MRK: 50%
100% MRK50/50100% EMLAF
Portfolio after 10yr
$245.0K
Annual income
$137,605.02/yr
Blended yield
56.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EMLAF
Analyst Ratings
1
Buy
Consensus: Buy
Price Target
$41.00
+12.9% upside vs current
Range: $41.00 — $41.00
Altman Z
2.7
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMLAF buys
0
MRK buys
0
No recent congressional trades found for EMLAF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMLAFMRK
Forward yield1.71%2.76%
Annual dividend / share$0.62$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR68.3%32.7%
Portfolio after 10y$433.3K$56.8K
Annual income after 10y$265,411.90$9,798.13
Total dividends collected$396.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$41.00$128.54

Year-by-year: EMLAF vs MRK ($10,000, DRIP)

YearEMLAF PortfolioEMLAF Income/yrMRK PortfolioMRK Income/yrGap
1$10,987$287.09$11,206$366.19$219.00MRK
2$12,252$496.14$12,650$502.35$398.00MRK
3$13,980$870.25$14,407$694.19$427.00MRK
4$16,521$1,561.85$16,585$967.82$64.00MRK
5← crossover$20,580$2,903.04$19,342$1,363.89+$1.2KEMLAF
6$27,709$5,688.18$22,913$1,947.19+$4.8KEMLAF
7$41,695$12,046.06$27,662$2,823.89+$14.0KEMLAF
8$73,124$28,510.54$34,159$4,173.35+$39.0KEMLAF
9$156,890$78,647.36$43,337$6,308.80+$113.6KEMLAF
10$433,284$265,411.90$56,776$9,798.13+$376.5KEMLAF

EMLAF vs MRK: Complete Analysis 2026

EMLAFStock

Empire Company Limited, together with its subsidiaries, engages in the food retail and related real estate businesses in Canada. It operates through two segments, Food Retailing, and Investments and Other Operations. The company owns, affiliates, and franchises approximately 1,600 retail stores under various retail banners, including Sobeys, Safeway, IGA, Foodland, FreshCo, Thrifty Foods, Farm Boy, Longo's, and Lawtons Drugs; and approximately 350 retail fuel locations, as well as operates grocery e-commerce stores under the banners, such as Voilà, Grocery Gateway, IGA.net, and ThriftyFoods.com. It also owns interest in the Crombie Real Estate Investment Trust, an open-ended real estate investment trust to own, operate, and develop a portfolio of grocery and pharmacy-anchored shopping centers, freestanding stores, and mixed-use developments; and various equity accounted interests in Genstar partnerships that develop residential real estate properties in Ontario, Western Canada, and the United States. The company was founded in 1907 and is headquartered in Stellarton, Canada.

Full EMLAF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EMLAF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMLAF vs SCHDEMLAF vs JEPIEMLAF vs OEMLAF vs KOEMLAF vs MAINEMLAF vs JNJEMLAF vs ABBVEMLAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.